Jie Huang
Nanjing University of Chinese Medicine(CN)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Neurofibromatosis and Schwannoma Cases, Cytokine Signaling Pathways and Interactions, Cancer-related molecular mechanisms research, Meningioma and schwannoma management
Most-Cited Works
- → Application of the Photocatalytic Chemistry of Titanium Dioxide to Disinfection and the Killing of Cancer Cells(1999)570 cited
- → Requirement of Histone Deacetylase Activity for Signaling by STAT1(2004)190 cited
- Inhibition of interferon gamma signaling by the short chain fatty acid butyrate.(2003)
- → MicroRNA Signature in Thyroid Fine Needle Aspiration Cytology Applied to “Atypia of Undetermined Significance” Cases(2011)101 cited
- → Oncogenic Ki-Ras Inhibits the Expression of Interferon-responsive Genes through Inhibition of STAT1 and STAT2 Expression(2003)79 cited
- → Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells(2009)61 cited
- → Oncogenic Ras Promotes Butyrate-induced Apoptosis through Inhibition of Gelsolin Expression(2004)61 cited
- → Histone Deacetylase Inhibitor AR-42 Differentially Affects Cell-cycle Transit in Meningeal and Meningioma Cells, Potently Inhibiting NF2 -Deficient Meningioma Growth(2012)60 cited
- → Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK(2021)51 cited
- → K-Ras, Intestinal Homeostasis and Colon Cancer(2015)44 cited